8x8 Inc vs Philip Morris International Inc. — how do they compare? 8x8 Inc trades at $1.93 (market cap $279.31M), while Philip Morris International Inc. trades at $186.8 (market cap $281.91B). The key difference: Philip Morris International Inc. is far larger — about 1009.3× 8x8 Inc's market cap, and Philip Morris International Inc. pays a 3.25% dividend while 8x8 Inc pays none. Which is the better fit depends on your goals.
| EGHT | PM | |
|---|---|---|
Market Cap | $279.31M | $281.91B |
Sector | Technology | Consumer Staples |
52-Week High | $2.76 | $191.86 |
52-Week Low | $1.59 | $144.33 |
Enterprise Value | $556.99M | $328.41B |
Dividend Yield | — | 3.25% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $175.95, down 2.35% amid a bearish technical signal and recent profit forecast revision. The company reported strong Q1 2026 EPS of $1.96, beating estimates, but faces headwinds from a $500 million impairment charge and margin pressures. Revenue growth remains steady, with 2025 revenue at $40.65 billion and net income margin of 26.74%. Analyst consensus is bullish with a $194 price target, though technical indicators show resistance near $179.
The stock presents a mixed outlook: solid fundamentals and high analyst buy ratings support upside potential, but near-term risks include cost pressures, currency volatility, and illicit market growth. Long-term investors may find value in the dividend and brand strength, while caution is warranted due to regulatory and macroeconomic challenges.
Trailing returns across standard periods
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →